Third degree AV block primary prevention: Difference between revisions

Revision as of 07:02, 1 July 2021

Patients with renal insufficiency, potassium, electrolyte disturbances, and dehydration are predisposed to develop digoxin toxicity.
Careful monitoring of electrolytes, drug levels, and renal function is essential in patients on chronic digoxin therapy.
[[Patients] on multiple AV nodal blocker agents (e.g., beta-blockers and calcium channel blockers) are at an increased risk for the development of atrioventricular (AV) block .
These patients should be carefully monitored for heart blocks.

@@ Line 1: / Line 1: @@
 __NOTOC__
+===Overview===
-Patients with renal insufficiency, potassium electrolyte disturbances, and dehydration are predisposed to develop [[digoxin toxicity]]. Careful monitoring of electrolytes, drug levels, and renal function is essential in patients on chronic digoxin therapy. Patients on multiple nodal agents (e.g., [[beta-blockers]] and [[calcium channel blockers]]) are at an increased risk for the development of third-degree atrioventricular (AV) block ([[Third degree AV block|complete heart block]]). These patients should be carefully monitored for heart blocks.
+===Primary prevention===
+* [[Patients]] with renal insufficiency, [[potassium]], [[electrolyte disturbances]], and [[dehydration]] are predisposed to develop [[digoxin toxicity]].
+* Careful monitoring of electrolytes, drug levels, and [[renal function]] is essential in [[patients]] on [[chronic]] [[digoxin ]] therapy.
+* [[Patients] on multiple AV nodal blocker agents (e.g., [[beta-blockers]] and [[calcium channel blockers]]) are at an increased risk for the development of [[atrioventricular (AV) block ]].
+* These [[patients]] should be carefully monitored for [[heart blocks]].
 <br />